(Q42256127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Giulio Rossi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Maria Cecilia Mengoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Alberto Cavazza

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Paolo Graziano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Alessandro Stefani

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

D Nicoli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Barbareschi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Cantaloni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Papotti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Tironi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Paci

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Migaldi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Sartori

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Pelosi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

13 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

61-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Large cell carcinoma of the lung: an endangered species?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

The fine structure of large cell undifferentiated carcinoma of the lung. Evidence for its relation to squamous cell carcinomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Large cell carcinoma of the lung. Ultrastructural and immunohistochemical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

Terminal respiratory unit type lung adenocarcinoma is associated with distinctive EGFR immunoreactivity and EGFR mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

EGFR mutations and the terminal respiratory unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1501-6

21 January 2018

Pathology of lung cancer

1 reference

12 December 2020

The histologic spectrum and significance of clear-cell change in lung carcinoma

1 reference

12 December 2020

Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer

1 reference

12 December 2020

Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update

1 reference

12 December 2020

Evaluation of adjunct immunohistochemistry on reporting patterns of non-small cell lung carcinoma diagnosed histologically in a regional pathology centre

1 reference

12 December 2020

Histologic type definition in clinical trials on advanced non-small cell lung cancer

1 reference

12 December 2020

Pathologic Diagnosis of Advanced Lung Cancer Based on Small Biopsies and Cytology: A Paradigm Shift

1 reference

12 December 2020

TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung

1 reference

12 December 2020

10.1007/S00428-013-1501-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 February 2020

1040376669

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24221342%20AND%20SRC:MED&resulttype=core&format=json